|
(Health-NewsWire.Net, October 15, 2021 )
Market Overview
A urinalysis is a urine examination. Urinary tract infections, kidney illness, and diabetes are among the disorders for which it is used to diagnose and treat. During a urinalysis, the appearance, concentration, and content of urine are all analyzed. Abnormal urine results may indicate sickness or illness.
View full report: https://www.datamintelligence.com/research-report/urinalysis-testing-products-market
Market Dynamics
The factors such as the growing geriatric population and related disorders are expected to drive the market growth. And the ease of the urinalysis test and the detailed results are expected to drive the global urinalysis testing products market.
The growing geriatric population and related disorders are expected to drive the market growth
According to WHO, By 2030, one out of every six persons on the planet will be 60 years old or older. The number of people aged 60 and more is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of adults aged 60 and up will have doubled (2.1 billion). The number of people between 2020 and 2050, aged 80 and more is predicted to treble, reaching 426 million. In elderly people, urinary tract infection and asymptomatic bacteriuria are prevalent.
It is difficult to tell the difference between asymptomatic urinary tract infection and asymptomatic bacteriuria in older persons, especially long-term care institutions because they're less likely to have localized genitourinary symptoms. In older persons, urinary tract infections (UTIs) are the most common type of bacterial infection. According to the National Institutes of Health, UTIs afflict about 10% of men and 20% of women over the age of 80.
A urinalysis and a urine culture with antibiotic susceptibility testing are the two most popular diagnostics for detecting UTIs: Urinalysis: A urinalysis consists of a series of physical, chemical, and microscopic tests performed on a urine sample. These tests look for bacteria and white blood cells, which are signs of infection.
A higher number of WBCs in the urine under a microscope, as well as a positive leukocyte esterase test, could indicate an infection or inflammation in the urinary tract. They indicate a urinary tract infection if they are also accompanied by bacteria. During a urinalysis, the appearance, concentration, and content of urine are all analysed. Sickness or illness might be indicated by abnormal urine results.
Urine can appear hazy rather than clear due to a urinary tract infection, for example. Renal impairment can be indicated by increased protein levels in the urine. Unusual urine findings frequently demand additional testing to pinpoint the source of the problem. As a result of rise in the elderly population and age-related disorders become more prevalent there is going to be a significant increase in the market growth.
The ease of the urinalysis test and the detailed results it provides is expected to drive the global urinalysis testing products market
Most urinalyses include the patient urinating into a specimen cup, which can be done at home or a doctor's office. A sample is sometimes asked first thing in the morning since more concentrated pee results are easier to read. A urinalysis is merely a pee examination.
It is a popular test that may be done in various places, including doctors' offices, urgent care centres, laboratories, hospitals, and even at home. A urine sample from the patient is collected in a specimen cup for a urinalysis test. Urinalysis testing usually only requires a modest sample of urine (30-60 mL). The sample can either be tested in a medical facility or sent to a laboratory for testing.
The abbreviation UA stands for Urinalysis. In general, UA is readily available and reasonably priced. It is also a straightforward test that can provide a wealth of information regarding various diseases and ailments. Because of the wealth of information that can be gathered about the health of the kidney or other internal disorders by this basic test, some clinicians refer to urinalysis as "a poor man's kidney Others."
A macroscopic analysis can assess urine's physical appearance (color, cloudiness, odour, and clarity). It can also be examined using chemical and molecular properties, as well as microscopic examination. Urinalysis can reveal signs and symptoms of diseases that have not yet manifested themselves. As a result, urinalysis is frequently used as part of routine health screening.
On March 6th, 2019, The FDA approved a smartphone-based at-home urine test that allows patients with chronic diseases, urinary tract infections, or high-risk pregnancies to track their health using a testing method as simple as shooting a smartphone selfie. Dip.io is a home-based urine test that the FDA has authorized. Through the Dip.io app, it allows smartphones to be used as a medical diagnostic tool.
Market Segmentation
Global Urinalysis Testing Products Market - By Product Type
Instruments
Consumables
Global Urinalysis Testing Products Market - By Application
Urinary Tract Infections (UTI)
Kidney diseases
Diabetes
Liver disease
Others
Global Urinalysis Testing Products Market - By End-User
Hospitals
Diagnostic Centers
Research laboratories
Homecare Settings
Global Urinalysis Testing Products Market - By Region
North America
Europe
South America
Asia Pacific
Middle East and Africa
Download free sample: https://www.datamintelligence.com/download-sample/urinalysis-testing-products-market
Geographical Analysis
North America region accounted for the largest market share in the global urinalysis testing products market
With increasing UTI problems and the latest product launches by major key players, this region is assumed to dominate the market.
In the United States, urinary tract infections (UTIs) are very frequent. Urinary tract infections (UTIs) are the second most prevalent type of infection in the body, accounting for more than 8 million hospital visits each year. A UTI affects about 10 out of every 25 women and 3 out of every 25 men at some point in their lives.
A urinary tract infection (UTI) occurs when an infection develops in the urinary tract. Urinalysis is the most frequently used test for the evaluation of potential urinary tract infection (UTI). In the U.S, urinalysis cost ranges from $30 to $247 depending on the depth of the panel.
On August 10th, 2020, Sysmex America, Inc. announced an exclusive agreement with Siemens Healthineers to distribute and service the Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use in North America.
To assist assure optimal efficiency and uniform testing, the CLINITEK Novus Automated Urine Analyzer combines dry-pad urine chemistry technology with a cassette test format.
Competitive Landscape
The global urinalysis testing products market is moderately competitive with the increasing incidence of diseases and demand for diagnosis equipment.
Some of the major key players in the global urinalysis testing products market are Erba Mannheim, Siemens Healthineers, URIT Medical Electronic Ltd, Roche Diagnostics, Beckman Coulter, Sysmex Corporation, DIRUI, Arkray Inc., Cardinal Health, and EKF Diagnostics.
Topic's you may be interested, Disposable Hospital Supplies Market, Severe Combined Immunodeficiency Diagnosis Market, Mortuary Equipment Market, Hydroalcoholic Gel Market, Operating Room Equipment Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
|
